QA: Teligent Inc. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000352998_2021_Teligent_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Liabilities', 'missing_ratio': 0.23541086742145273, 'aggregate_val': 197940000, 'exp_sum': 160222000, 'exp_to_value': {'LiabilitiesCurrent': 23121000, 'LiabilitiesNoncurrent': 4914000, 'remainder_Liabilities': 132187000}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000352998')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000352998, Teligent Inc.

  xvar xval
0 AssetsCurrent 44,291,000
1 IntangibleAssetsNetIncludingGoodwill 23,465,000
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 20,032,000
4 LiabilitiesCurrent 23,121,000
5 LiabilitiesNoncurrent 4,914,000
6 remainder_Liabilities 169,905,000
7 CostOfGoodsAndServicesSold 49,031,000
8 SellingGeneralAndAdministrativeExpense 27,011,000
9 ResearchAndDevelopmentExpense 7,674,000
10 remainder_Expenses 112,654,000
11 remainder_Revenues 48,658,000
12 remainder_NetIncome 25,690,000
13 remainder_ComprehensiveNetIncome 264,000
  yvar yval
0 Assets 87,788,000
1 Liabilities 197,940,000
2 Expenses 196,370,000
3 Revenues 48,658,000
4 StockholdersEquity -110,152,000
5 NetIncome -122,022,000
6 ComprehensiveNetIncome -121,890,000
7 BaseVar 278,355,000
8 EconomicCapitalRatio -2.18

Edgar->Model Mapping

Feature Distribution

Change over Time